NCT00846222

Brief Summary

The purpose of this study is evaluate the safety and feasibility of mild therapeutic hypothermia (TH) during and 12 hours after primary percutaneous coronary intervention for acute myocardial infarction complicated with shock

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Feb 2009

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2009

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

February 16, 2009

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 18, 2009

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2010

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2010

Completed
Last Updated

February 18, 2009

Status Verified

February 1, 2009

Enrollment Period

1.2 years

First QC Date

February 16, 2009

Last Update Submit

February 17, 2009

Conditions

Outcome Measures

Primary Outcomes (1)

  • Primary en point: presence of major adverse cardiac events (MACE) MACE definition: death and non-fatal re-infarction.

    30 days

Secondary Outcomes (1)

  • Infarct size calculated by area under thr curve creatinine kinase according consecutive samples Reversal stunning by blinded observer echocardiographic assessment

    30 days

Study Arms (1)

Mild theraputic hypothermia

EXPERIMENTAL
Procedure: Hypothermia

Interventions

HypothermiaPROCEDURE

Mild therapeutic hypothermia, 33-34 celsius, for 12 hours

Mild theraputic hypothermia

Eligibility Criteria

Age18 Years - 88 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Recent myocardial infarction: 24 hours of start pain
  • Pump failure cardiogenic shock (defined as persistent hypotension, systolic BP \< 90 mmHg, despite fluids and catecholamines infusion, with tissue hypoperfusion signs
  • Candidate for immediate percutaneous reperfusion
  • Maximal care support: mechanical ventilation, intraaortic balloon contrapulsation

You may not qualify if:

  • Cardiogenic shock related to mechanical complication: free wall rupture, acute mitral regurgitation, acute VSD, tamponade
  • Pregnant women
  • Absence of maximal support care

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assaf Harofeh MC

Ẕerifin, 70300, Israel

Location

Related Publications (2)

  • Dixon SR, Whitbourn RJ, Dae MW, Grube E, Sherman W, Schaer GL, Jenkins JS, Baim DS, Gibbons RJ, Kuntz RE, Popma JJ, Nguyen TT, O'Neill WW. Induction of mild systemic hypothermia with endovascular cooling during primary percutaneous coronary intervention for acute myocardial infarction. J Am Coll Cardiol. 2002 Dec 4;40(11):1928-34. doi: 10.1016/s0735-1097(02)02567-6.

    PMID: 12475451BACKGROUND
  • Hale SL, Dave RH, Kloner RA. Regional hypothermia reduces myocardial necrosis even when instituted after the onset of ischemia. Basic Res Cardiol. 1997 Oct;92(5):351-7. doi: 10.1007/BF00788947.

    PMID: 9486356BACKGROUND

Study Design

Study Type
interventional
Phase
phase 3
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER GOV

Study Record Dates

First Submitted

February 16, 2009

First Posted

February 18, 2009

Study Start

February 1, 2009

Primary Completion

April 1, 2010

Study Completion

July 1, 2010

Last Updated

February 18, 2009

Record last verified: 2009-02

Locations